《星岛》见习记者 黄宸 深圳报道11月25日,云南白药(000538.SZ)公告称,11月21日,中信证券、中信保诚资产等机构代表在其总部现场调研。公司方面,由董事会秘书钱映辉及投关团队接待,期间,就药品与健康品业务进展、核药研发、线上渠道建设等议题做出详细介绍。药品事业群稳健增长2025年上半年,药品事业群实现主营业务收入47.51亿元,同比增长10.8%。其中,云南白药气雾剂销售收入达...
Source Link《星岛》见习记者 黄宸 深圳报道11月25日,云南白药(000538.SZ)公告称,11月21日,中信证券、中信保诚资产等机构代表在其总部现场调研。公司方面,由董事会秘书钱映辉及投关团队接待,期间,就药品与健康品业务进展、核药研发、线上渠道建设等议题做出详细介绍。药品事业群稳健增长2025年上半年,药品事业群实现主营业务收入47.51亿元,同比增长10.8%。其中,云南白药气雾剂销售收入达...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.